The storied success of copyright’s flagship drug has undeniably shaped the pharmaceutical landscape. However, putting money in companies heavily dependent on copycat drugs and the waning patent rights https://linkedbookmarker.com/story7004153/the-blue-pill-and-pharmaceutical-companies-a-risky-opportunity